Evidence map›Paper›PMID 42905663›Full record

ArticlePloS one2026

Implant selection at elective aseptic revision of a primary total knee replacement: A scoping review and map of the evidence.

Ben Tyas, John Norman, Shivam Nitin Kolhe, Melissa Harden, Catherine Hewitt, David Deehan, Paul Baker

Abstract readScoping Review
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ben TyasDepartment of Health Sciences, University of York, York, United Kingdom.ORCID https://orcid.org/0000-0002-7858-4988
John NormanAcademic Centre for Surgery, University Hospitals Tees, Middlesbrough, United Kingdom.
Shivam Nitin KolheDepartment of Health Sciences, University of York, York, United Kingdom.ORCID https://orcid.org/0000-0002-9238-638X
Melissa HardenCentre for Reviews and Dissemination, University of York, York, United Kingdom.
Catherine HewittDepartment of Health Sciences, University of York, York, United Kingdom.ORCID https://orcid.org/0000-0002-0415-3536
David DeehanTrauma & Orthopaedics, Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
Paul BakerDepartment of Health Sciences, University of York, York, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe recent James Lind Alliance (JLA) Priority Setting Partnership (PSP) on 'the problematic knee replacement' highlighted implant selection at revision knee arthroplasty (rTKA) as a 'Top 10' research priority. The aims of this scoping review are to map the evidence for the implants used at first-time elective aseptic rTKA, to identify gaps in the evidence-base, and to provide recommendations for future research.

methodsA scoping review was conducted in accordance with the Arksey and O'Malley framework and the Joanna Briggs Institute Manual for Evidence Synthesis, and reported according to the PRISMA extension for Scoping Reviews. A comprehensive search of MEDLINE, Embase, CINAHL, CDSR, CENTRAL, DARE, HTA, SCI, PROSPERO and KSR Evidence was conducted on 17th August 2026, covering studies published between 2000 and 2026. Annual reports of 17 national joint replacement registries (NJRRs) were also sought. The review was registered on the Open Science Framework (https://doi.org/10.17605/OSF.IO/SD49V).

resultsFollowing deduplication, 7,096 research articles and 155 NJRR reports were identified. After applying eligibility criteria, 121 research articles and six NJRR reports were included. Twenty-two studies (18%) had cohorts clearly defined as exclusively comprising first-time elective aseptic rTKA procedures. The evidence consisted mostly of retrospective case series (45/121, 37%) and retrospective comparative studies (41/121, 34%). Most evidence was Level IV (48/121, 40%) or Level III (46/121, 38%) with no Level I evidence identified. Approximately half the studies were from the United States (58/102, 48%). Five studies (4%) reported mean or median follow up ≥10 years. A map of the evidence, tabulated by five key themes, is presented.

conclusionsThere is a lack of high-level comparative evidence to support implant selection at first-time elective aseptic rTKA. Future research should focus on more clinically homogeneous cohorts and compare outcomes associated with cemented versus hybrid/cementless stems, constraint levels, and metaphyseal fixation devices.

Indexed as

Arthroplasty, Replacement, KneeKnee ProsthesisReoperationHumans

Identifiers

PMID42905663
PMCPMC13686483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.